Sterneck Capital Management, LLC Tyme Technologies, Inc. Transaction History

Sterneck Capital Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 03, 2022	SELL	$0.28 - $0.68 $4,200 - $10,200	-15,000 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$1.14 - $1.87 $17,100 - $28,050	15,000 New	15,000 $18,000

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

Get notified when there are updates to the investment portfolio of Sterneck Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sterneck Capital Management, LLC with notifications on news.